All Protocols›Advanced

The Furnace: Advanced Lipolysis

Thyroid and pancreas cytomax plus Tesamorelin, AOD-9604, Retatrutide, and 5-amino-1MQ. Visceral fat stack, not a stimulant fat burner.

Duration

8-16 weeks with titration; oral cytomax 20-30 days

First Results

GLP-1 satiety in days; Tesamorelin VAT is slower

Peptides in Stack

6

1Overview

“Appetite and VAT tools stacked on thyroid/pancreas cytomax. Muscle preservation still requires protein and lifting. This is more aggressive than our standard fat-loss protocol. Retatrutide is investigational in many jurisdictions. Titrate or you will be hugging a toilet.”

Ideal Candidates

✓People with stubborn visceral fat who already understand GLP-1 titration
✓Those considering Tesamorelin specifically for VAT, not as generic HGH
✓Advanced users stacking lipolytic fragments with a clinician watching HR and GI side effects

Contraindications

✕History of medullary thyroid cancer / MEN2 for GLP-1 class drugs
✕Pregnancy
✕Eating disorders
✕Unsupervised stacking of triple agonists at "hero" doses

2The Science

Atlas's triple vector: GLP-1/GIP/glucagon agonism (Retatrutide), GH-axis lipolysis (Tesamorelin, AOD-9604), and a metabolic brake story (5-amino-1MQ / NNMT). Thyreogen and Suprefort are the oral endocrine chassis so calorie cuts do not immediately flatten thyroid and pancreatic signaling. Zone 2 oxidizes what you mobilize. Peptides that dump fatty acids without a hike just recirculate them.

3Clinical Evidence

Moderate Evidence
25 human studies40 animal studies20 in vitro

Key Findings

1

Tesamorelin reduced visceral adipose tissue in HIV-associated lipodystrophy trials (FDA label context)

2

Retatrutide Phase 2 obesity data showed large weight-loss effect sizes with GI and HR caveats

3

AOD-9604 human fat-loss RCTs are mixed; treat it as adjunct, not the king

Study Limitations

  • ⚠Compounded GLP-1s and research Retatrutide are not the same as a branded trial product.
  • ⚠5-amino-1MQ human data is thinner than the marketing.

3The Peptide Stack

TH

Thyreogen

View Profile →

Thyroid cytomax. Not a replacement for indicated levothyroxine.

Mechanism: Oral thyroid complex; morning, empty stomach.

Half-life: ~30 minutes (estimated)Dose range: 1-2 capsules/day
SU

Suprefort

View Profile →

Pancreas cytomax with the largest meal in Atlas language.

Mechanism: Oral pancreatic complex.

Half-life: ~30 minutes (estimated)Dose range: 1-2 capsules/day
TE

Tesamorelin

View Profile →

GHRH analog with an FDA visceral-fat indication in HIV lipodystrophy. Fasted dosing matters.

Mechanism: Lipolytic GH pulses; 1-2 mg SubQ, empty stomach, no food ~90 min after.

Half-life: ~26-38 minutesDose range: 1-2 mg/day
AO

AOD-9604

View Profile →

HGH C-terminal fragment aimed at lipolysis without IGF-1 / glucose drama of full GH.

Mechanism: Fragment 176-191 analog; daily fasted SubQ in community use.

Half-life: ~30 minutes (estimated)Dose range: 300-500 mcg/day
RE

Retatrutide

View Profile →

GLP-1/GIP/glucagon triple agonist. Potent. Slow titration. Watch resting HR.

Mechanism: Weekly injectable; start low.

Half-life: ~144 hours (6 days)Dose range: 1-12 mg/week
5-

5-Amino-1MQ

View Profile →

NNMT inhibitor used orally in fat-loss stacks. Not a peptide calculator problem; still a library leaf.

Mechanism: NAD+ / NNMT story; daily oral in community ranges.

Half-life: ~4-6 hours (estimated)Dose range: 50-100 mg/day (oral)

4Protocol Tiers

Tier 1: Thyroid + pancreas cytomax

Thyreogen morning empty stomach; Suprefort with the largest meal. Chassis, not the fat loss.

Duration
20-30 days
Frequency: Daily
Thyreogen1-2 capsules
Timing: Morning, empty stomach
Suprefort1-2 capsules
Timing: With largest meal

Tier 2: Tesamorelin + AOD-9604

Fasted GH-axis lipolysis. Food in the window kills the point.

Duration
8-12 weeks
Frequency: Daily
Tesamorelin1-2 mg
Timing: AM or bedtime, strictly fasted; no food 90 min after
AOD-9604300 mcg
Timing: Fasted, often with Tesamorelin window

Tier 3: Retatrutide + 5-amino-1MQ

Weekly triple agonist plus oral NNMT inhibitor. Physician for Retatrutide if you have one.

Duration
Titrate monthly; do not jump doses
Frequency: Retatrutide weekly; 5-amino-1MQ daily
RetatrutideStart low (trial-style titration, not a hero dose)
Timing: Weekly
5-Amino-1MQ50-150 mg oral (community)
Timing: Daily

5Lifestyle Integration

Peptides are one input in a larger system. Without these non-negotiable lifestyle factors, even the best protocol will underperform.

🏋️Training

Zone 2 45 min, 4x/week is the Atlas oxidation rule. Lift 2-3x so GLP-1s do not eat your gym.

🥗Nutrition

Protein high, calories in a deficit you can live with. 3-4 L water if you are actually oxidizing fat.

🌙Sleep

GH-axis peptides at night need sleep. GLP-1 nausea wrecks sleep; titrate.

🧘Stress Management

Cortisol and alcohol both fight VAT loss. Boring but true.

6Timeline & Expectations

Weeks 1-4

What You'll NoticeSatiety if Retatrutide is on board. Tesamorelin waist changes are slower.
What's Happening BiologicallyTitration. If you are gray-green, you went too fast.

Weeks 5-12

What You'll NoticeRecomposition if protein and lifting held. Scale is not VAT.
What's Happening BiologicallyLipolytic pulses plus GLP-1 intake control.

Off-ramp

What You'll NoticeWeight rebound is the default if habits were the peptides. Plan the exit.
What's Happening BiologicallyDo not cold-turkey a high Retatrutide dose without a plan.

7Monitoring & Safety

Key Metrics to Track

Resting heart rateTriple agonists can raise HR. Stop and call a doctor if it is a new persistent tachycardia.
Waist / photos, not only scaleTesamorelin is a VAT story. The scale lies if you are also lifting.
Thyroid labs if you already have diseaseThyreogen is not your synthroid. Do not freelance replacement therapy.

Troubleshooting

Brutal nausea
Possible Causes
  • Retatrutide jump
  • Food too close to Tesamorelin
Solutions
  • Hold the GLP-1 dose
  • Respect the fasted window
  • Ginger and smaller meals, not a second agonist
Strength collapsing
Possible Causes
  • Too little protein
  • Too large a deficit
Solutions
  • Lift, eat protein, slow the GLP-1
  • AOD-9604 will not save a 1200 kcal crash

8Further Reading

Dive deeper into the individual peptides and methodologies behind this protocol.

Tesamorelin: The FDA-Approved GHRH Analog for Visceral Fat - Dosing, Mechanism & Off-Label Use

Tesamorelin is the only FDA-approved peptide for reducing visceral adipose tissue. Complete guide covering mechanism of action, dosing protocols, reconstitution math, and clinical evidence.

Read article →

Retatrutide: The Triple Agonist GLP-1 Peptide - Dosing and PK Guide

Comprehensive guide to retatrutide covering its triple agonist mechanism, 6-day half-life, and Phase II dose escalation.

Read article →

5-Amino-1MQ: The NNMT Inhibitor That Raises NAD+ and Targets Fat

5-Amino-1MQ inhibits NNMT to raise intracellular NAD+ and reduce fat storage. Mechanism, dosing, evidence, and comparison.

Read article →

Semaglutide vs Tirzepatide vs Retatrutide: The Complete GLP-1 Triple Comparison

Single, dual, and triple agonist GLP-1 peptides compared head-to-head. Clinical weight loss data, dose schedules, side effects, and which to choose for your goals.

Read article →

Tools for This Protocol